Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gershon

Showing results (21-30 of 656) with videos related to

Pageof 66
Sort By:
Nature|November 23, 2000
Structural genomics--from cottage industry to industrial revolutionD Gershon
Nature|May 23, 2000
Are mega-mergers good medicine for the pharmaceutical industry?D Gershon
Nature|July 7, 1994
US panel firms up views on embryo researchD Gershon
Nature|March 17, 1994
Health reforms 'could hit biotech companies'D Gershon
Nature|April 28, 1994
But are opposed in US CongressD Gershon
Nature|July 5, 1990
Biomedical research. Young researchers go shortD Gershon
Nature|June 28, 1990
Orphan Drug Act. Winners to keep allD Gershon
Nature|April 26, 1990
Biotechnology patent disputes. Market machinationsD Gershon
Nature|April 5, 1990
Leading biotechnology companies quit the IBAD Gershon
Nature|November 16, 1989
Anti-clotting drugs. Approval for TPA competitorD Gershon
Pageof 66

Showing results (21-30 of 656) with videos related to

Sort By:
Pageof 66
Nature|November 23, 2000
Structural genomics--from cottage industry to industrial revolutionD Gershon
Nature|May 23, 2000
Are mega-mergers good medicine for the pharmaceutical industry?D Gershon
Nature|July 7, 1994
US panel firms up views on embryo researchD Gershon
Nature|March 17, 1994
Health reforms 'could hit biotech companies'D Gershon
Nature|April 28, 1994
But are opposed in US CongressD Gershon
Nature|July 5, 1990
Biomedical research. Young researchers go shortD Gershon
Nature|June 28, 1990
Orphan Drug Act. Winners to keep allD Gershon
Nature|April 26, 1990
Biotechnology patent disputes. Market machinationsD Gershon
Nature|April 5, 1990
Leading biotechnology companies quit the IBAD Gershon
Nature|November 16, 1989
Anti-clotting drugs. Approval for TPA competitorD Gershon
Pageof 66